🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Some experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, legal action or imprisonment.

Platform Response and Material Removal

According to TikTok, the platform has removed violative material and banned related hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or administering at home.

After moments of joining one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.

Item Details and Costs

Within these groups, messages show dark colored packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to potentially significant medical dangers”.